CClinicalTrials.gg
CompletedNCT06074445Updated Oct 10, 2023

Caring for the Sexual Health and Wellbeing of Cancer Survivors and Their Intimate Partners: An Anonymous Survey

An observational study in Cancer, sponsored by Bournemouth University. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-10.

Sponsored by Bournemouth University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
169
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this survey study is to provide broad information as reported by cancer survivors and their intimate partners about both their sexual health and their experiences of care from the United Kingdom hospital cancer team, including their perspectives on factors that may hinder or help care. This information will be analysed and used to inform the questions asked in a separate, subsequent, qualitative study.

02

Conditions studied

  • Cancer

Keywords

  • Cancer Survivors
  • Neoplasms
  • Oncology
  • Sexual Health
  • Sexual Dysfunction, physiological
  • Sexual Dysfunctions, psychological
  • Sexuality
  • Barrier
  • Facilitator
  • Professional-Patient Relations
  • Communication
03

In context

Lead sponsor

Bournemouth University is the lead sponsor of 52 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

People with cancer or the partners of people with cancer

Inclusion criteria

  1. Cancer survivors diagnosed with any type of cancer at age 18 years or over
  2. A partner of someone diagnosed with any type of cancer at age 18 years or over
  3. Cancer diagnosis must be no more than 10 years ago
  4. Cancer survivors or their partners who experienced treatment and follow up care in the United Kingdom

Exclusion criteria

Exclusion Criteria:

  1. Cancer survivors who were diagnosed with cancer below the age of 18 years
  2. Partners of cancer survivors who were diagnosed with cancer below the age of 18 years
  3. Cancer diagnosis was more than 10 years ago
  4. Cancer survivors/partners of survivors where the cancer treatment and follow up was not in the United Kingdom
  5. Previous completion of the survey
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
169 participants (actual)
Patient registry
No

Groups and cohorts

  • People with Cancer

    No intervention

    Other: No intervention

  • Partners of People with Cancer

    No intervention

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Number of participants who had a sexual health discussion(s) with the hospital cancer team at any point during cancer care

    Sexual health discussion:19 examples of the sort of topics that may have been discussed in relation to sexual health

    Time frame: Up to 10 years prior to completing survey (discussion(s) about sexual health could have occurred at any point during cancer care)

Secondary outcomes

  1. Number of participants with specific levels of impact on their sex lives by cancer and its treatments

    As above

    Time frame: From each individual participants' cancer diagnosis/cancer treatment until the date that they completed the survey

  2. Survey questionnaire to measure the nature and prevalence of care for sexual health that cancer survivors and their intimate partners self-report experiencing from the UK hospital cancer team.

    An online survey questionnaire (no validated questionnaire available and therefore research created the questionnaire based on a literature reviews on sexual health in oncology

    Time frame: Participants can report care received from prior to their cancer treatment through to their follow-up care (last 10 years only)

  3. Survey questionnaire to measure the nature and prevalence of the perceived barriers to and facilitators for care for sexual health as received by cancer survivors and their intimate partners when provided by the UK hospital cancer team.

    As above

    Time frame: Participants can report their perceptions from diagnosis through to their follow-up care (last 10 years only)

  4. Survey questionnaire to measure to what extent groups of cancer survivors and their intimate partners with differing characteristics receive differing care for their sexual health from the UK hospital cancer team.

    Participants' responses from outcomes 1-4 will be used toinform this outcome

    Time frame: Participants diagnosed with cancer in the previous 10 years.

07

Study locations

1 site
  • Bournemouth University
    Bournemouth, Dorset BH8 8AJ, United Kingdom
08

References and documents

Individual participant data

Plan to share: No — Participant information sheet stated that information would not be made publicly available via a data sharing repository. This approach was taken due to the sensitive nature of the topic and was anticipated to provide reassurance and potentially improve recruitment.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06074445
Lead sponsor
Bournemouth University
Collaborators
National Institute for Health Research, Applied Research Collaboration, Wessex, Fortuneswell Cancer Trust, Dorset County Hospital NHS Foundation Trust
Responsible party
Sponsor
First posted
Oct 10, 2023
Start date
Aug 23, 2022
Primary completion
Sep 30, 2022
Completion
Sep 30, 2022
Last update
Oct 10, 2023

Study contacts

Sam Porter, PhD, RN
principal investigator · Bournemouth University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion